Assessment of risk factors for Korean children with Kawasaki disease

Pediatric Cardiology

Volumn 33, Issue 4, 2012, Pages 513-520

  Kim, Jae Jung ^a   Hong, Young Mi ^b   Yun, Sin Weon ^c   Han, Myung Ki ^d   Lee, Kyung Yil ^e   Song, Min Seob ^f   Lee, Hyoung Doo ^g   Kim, Dong Soo ^h   Sohn, Sejung ^b   Ha, Kee Soo ⁱ   Hong, Soo Jong ^a   Kim, Kwi Joo ^a   Park, In Sook ^a   Jang, Gi Young ⁱ   Lee, Jong Keuk ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

^d University of Ulsan   (South Korea)

^e Daejeon St Mary's Hospital   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g Pusan National University Hospital   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

ⁱ Korea University Ansan Hospital   (South Korea)

Author keywords

Coronary artery lesions; Intravenous immunoglobulin; Kawasaki disease; Korean; PELI1 gene

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN; PELI1 PROTEIN; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CORONARY ARTERY DISEASE; DRUG MEGADOSE; FEMALE; FEVER; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFANT; KOREA; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

CHILD, PRESCHOOL; CORONARY VESSELS; DNA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MALE; MORBIDITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 84863432745     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-011-0143-1     Document Type: Article

References (33)

1. Ashouri N, Takahashi M, Dorey F, Mason W (2008) Risk factors for nonresponse to therapy in Kawasaki disease. J Pediatr 153: 365-368
2. Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW (1998) A predictive instrument for coronary artery aneurysms in Kawasaki disease. Am J Cardiol 81:1116-1120 (Pubitemid 28232682)
3. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, Ling L, Wright VJ, Thalamuthu A, Odam M, Shimizu C, Burns JC, Levin M, Kuijpers TW, Hibberd ML, International Kawasaki Disease Genetics Consortium (2009) A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet 5:e1000319
4. Burns JC, Glodé MP (2004) Kawasaki syndrome. Lancet 364: 533-554
5. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T (1996) Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 28:253-257 (Pubitemid 26266648)
6. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17:1144-1148 (Pubitemid 29023891)
7. Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, Gerber M, Shulman ST, Karchmer AW, Wilson W, Peter G, Durack DT, Rahimtool SH (1994) Guidelines for longterm management of patients with Kawasaki disease: report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 89:916-922
8. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW (1998) Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 133:254-258 (Pubitemid 28385204)
9. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057-1061
10. Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145-148 (Pubitemid 36920035)
11. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Hirose O, Yokoyama T, Baba K, Mori C (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055-1058 (Pubitemid 15211522)
12. Harada K (1991) Intravenous gamma globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33:805-810
13. Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED (2003) Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 24:122-126 (Pubitemid 36920031)
14. Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H (1992) Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet 340:1127-1129
15. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379-1385 (Pubitemid 26307269)
16. Kim JJ, Hong YM, Sohn S, Jang GY, Ha KS, Yun SW, Han MK, Lee KY, Song MS, Lee HD, Kim DS, Lee JE, Shin ES, Jang JH, Lee YS, Kim SY, Lee JY, Han BG, Wu JY, Kim KJ, Park YM, Seo EJ, Park IS, Lee JK, Korean Kawasaki Disease Genetics Consortium (2011) A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet 129:487-495
17. Koren G, Lavi S, Rose V, Rowe R (1986) Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108: 388-392 (Pubitemid 16125957)
18. Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD (2010) Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr 99:1578-1583
19. Lehman TJ, Mahnovski V (1988) Animal models of vasculitis. Lessons we can learn to improve our understanding of Kawasaki disease. Rheum Dis Clin N Am 14:479-487
20. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S (2000) Predictors of coronary artery lesions after intravenous gamma globulin treatment in Kawasaki disease. J Pediatr 137:177-180 (Pubitemid 30659223)
21. Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, Katoh T, Baba K, Furusho K, Okuni M, Osano M (2000) Coronary risks after high-dose gamma globulin in children with Kawasaki disease. Pediatr Int 42:464-469
22. Moynagh PN (2009) The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling. Trends Immunol 30:33-42
23. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747-2771 (Pubitemid 39453026)
24. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, Shulman ST, Wiggins JW, Hicks RV, Fulton DR, Lewis AB, Leung DYM, Colton T, Rosen FS, Melish ME (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347 (Pubitemid 16060087)
25. Rosenkranz ME, Schulte DJ, Agle LM, Wong MH, Zhang W, Ivashkiv L, Doherty TM, Fishbein MC, Lehman TJ, Michelsen KS, Arditi M (2005) TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease. Circulation 112:2966-2973 (Pubitemid 41612299)
26. Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, Yashiro M, Nakamura Y, Yanagawa H (2007) Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 49:421-426 (Pubitemid 46961850)
27. Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol 16:3-9 (Pubitemid 38147427)
28. Terai M, Shulman ST (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131:888-893 (Pubitemid 28027615)
29. Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y (2003) Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 108:325-330 (Pubitemid 36899024)
30. Welzing L, von Kleist-Retzow JC, Kribs A, Eifinger F, Huenseler C, Sreeram N (2009) Rapid development of life-threatening complete atrioventricular block in Kearns-Sayre syndrome. Eur J Pediatr 168:757-759
31. Yasukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y, Rowley AH (2002) Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 105:766-769 (Pubitemid 34157383)
32. Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K, Son C, Lee J (2009) Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr 168:157-162
33. Yu HR, Kuo HC, Huang EY, Liang CD, Hwang KP, Lin IC, Sheen JM, Wang TJ, Wang CL, Yang KD (2010) Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease. Pediatr Cardiol 31:1151-1156